In this session, Nancy Sajjadi and Steve Walfish introduce 4 speakers and posit several questions to address hot topics in bioassay design, development and validation: Generating and evaluating the standard curve, establishing equivalence…
https://email@example.com://firstname.lastname@example.org 00:11:572021-09-28 09:46:24Co-chair panel Bioassays and statistics FAQs to FACTS
This paper, cited over 200 times, summarizes a phase 1 dose escalation study, 13 subjects with hemophilia A received by peripheral intravenous infusion a retroviral vector carrying a B-domain–deleted human factor VIII (hFVIII) gene. This was…
https://email@example.com://firstname.lastname@example.org 15:25:112021-09-28 09:22:32Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion
This white paper encouraged advocates of the adenovirus standard to carefully examine its use in the field. It was originally presented at conference in 2003 but the article has recently been made open access (https://www.bioprocessingjournal.com/afp/J25-Sajjadi.pdf)…
https://email@example.com://firstname.lastname@example.org 16:00:532021-09-28 09:23:10Defining a Detailed Approach to Using the Adenovirus Reference Material (ARM)
In this paper, we demonstrated that a PCR assay to detect vector was fit for its intended purpose. In collaboration with Kim Boekelheide at Brown University, my group addressed a key regulatory concern for integrating vectors- potential for…
https://email@example.com://firstname.lastname@example.org 15:58:112021-09-28 09:24:01Analysis of testes and semen from rabbits treated by intravenous injection with a retroviral vector encoding the human factor VIII gene: no evidence of germ line transduction
This paper summarizes the proceedings of a conference held to discuss the development of an adenoviral vector standard. In response to the tragic death of Jesse Gelsinger, dose related toxicity became a focus in the field of gene therapy.…
https://email@example.com://firstname.lastname@example.org 15:28:062021-09-28 09:24:45Working toward an adenoviral vector testing standard
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
Essential Website Cookies
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
Other external services
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: